BIIB

Biogen Idec Inc. Press Releases

$409.59
*  
0.51
0.12%
Get BIIB Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Rexford Industrial to Present at the 2015 Citi Global Property CEO Conference
2/27/2015 7:00:00 AM - Business Wire


Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 ALPROLIX® Pediatric Study
2/27/2015 7:00:00 AM - Business Wire


Biogen Idec to Present at the Cowen and Company 35th Annual Healthcare Conference
2/23/2015 4:01:00 PM - Business Wire


Biogen Idec, Columbia University and HudsonAlpha Institute Identify New ALS Gene and Signaling Pathways
2/19/2015 2:05:00 PM - Business Wire


Biogen Idec, Columbia University and HudsonAlpha Institute Identify New ALS Gene and Signaling Pathways
2/19/2015 2:05:00 PM - Business Wire


Biogen Idec to Present at the 2015 RBC Capital Markets’ Global Healthcare Conference
2/17/2015 4:01:00 PM - Business Wire


RBCC Joint Venture Partner n3D to Present Latest 3D Bioprinting Research in Washington, D.C.
2/10/2015 5:00:00 AM - Business Wire


Developers #HackMS at the First Ever Hackathon for Multiple Sclerosis
2/9/2015 8:32:00 AM - PR Newswire


Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease
2/5/2015 7:00:00 AM - PR Newswire


RBCC and n3D Pursue New Partnership Opportunities After Highly Successful 3D Bioprinting Exhibit at Biotech Showcase 2015
2/5/2015 5:00:00 AM - Business Wire


Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA Biomarkers in Multiple Sclerosis
2/2/2015 8:00:00 AM - PR Newswire


Kansas City Southern Increases Common Stock Dividend and Declares Dividends on 4% Non-Cumulative Preferred Stock; Establishes Annual Meeting Date
1/29/2015 5:00:00 PM - Business Wire


Biogen Idec 2014 Revenues Increase 40% to $9.7 Billion
1/29/2015 4:01:00 PM - Business Wire


Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Announce Global Collaboration to Develop Gene Therapies for Hemophilia
1/29/2015 4:40:00 AM - Business Wire


NFL Hall of Famer Earl Campbell And Son Tyler Campbell Pair Up With Biogen Idec To Celebrate The Inspiring Stories Of People With Relapsing Multiple Sclerosis
1/28/2015 8:00:00 AM - PR Newswire
▲13.15 % Price Change since this news event. The Volume Ratio is 1.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synergy Strips Corp. Acquires Assets of America’s No.1 Brain Health Supplement, FOCUSfactor
1/26/2015 5:25:00 PM - Business Wire


CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 29, 2015
1/26/2015 5:25:00 PM - Business Wire
▲13.70 % Price Change since this news event. The Volume Ratio is 0.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


European Medicines Agency Accepts Samsung Bioepis' Enbrel(R) Biosimilar Candidate, SB4, for Regulatory Review
1/21/2015 9:00:00 AM - PR Newswire


3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco
1/13/2015 5:00:00 AM - Business Wire
▲17.75 % Price Change since this news event. The Volume Ratio is 0.95.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals
1/11/2015 8:00:00 PM - Business Wire
▲19.59 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations
1/9/2015 8:00:00 AM - GlobeNewswire


Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research
1/9/2015 8:00:00 AM - Business Wire
▲16.94 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis
1/8/2015 7:30:00 AM - Business Wire
▲16.03 % Price Change since this news event. The Volume Ratio is 3.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28, 2015
12/23/2014 4:01:00 PM - Business Wire
▲21.99 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biogen Idec to Present at the 33rd Annual J.P. Morgan Healthcare Conference
12/22/2014 4:01:00 PM - Business Wire
▲16.27 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day